Tumor-derived TP53 variants
1 paper
- Human trial1
Latest
1 in 12 monthsJournal of Gynecologic Oncology
cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer
Trial in 35 peopleReproductive system